Breast Cancer Reoperation Rates Vary Widely by Surgeon

This article originally appeared here.
Breast Cancer Reoperation Rates Vary Widely by Surgeon
Breast Cancer Reoperation Rates Vary Widely by Surgeon

(HealthDay News) -- The 90-day rate of reoperation following breast conservation surgery (BCS) for early-stage breast cancer has decreased overall and varies widely by surgeon, according to research published online Feb. 17 in JAMA Surgery.

Abby J. Isaacs, of Cornell Medical College in New York City, and colleagues analyzed data for the period 2003 to 2013, from a New York State mandatory reporting database, for a population-based sample of 89,448 women undergoing primary BCS for cancer. Rates of reoperation within 90 days of the initial BCS procedure and factors affecting reoperation were assessed.

The researchers found that the overall rate of 90-day reoperation averaged 30.9 percent and decreased over time from 39.5 percent in 2003-2004 to 23.1 percent in 2011-2013. Rates of reoperation were highest in women aged 20 to 49 years (37.7 percent) and lowest in women aged 65 years or older (26.3 percent) (P < 0.001 for trend). Rates of reoperation varied widely by surgeon, from 0 to 100 percent. Unadjusted rates of reoperation were 35.2 percent for low-volume surgeons (<14 cases per year), 29.6 percent for middle-volume surgeons (14 to 33 cases per year), and 27.5 percent for high-volume surgeons (≥34 cases per year).

"Nearly one in four women underwent a reoperation within 90 days of BCS across New York State from 2011 to 2013, compared with two in five from 2003 to 2004," the authors write. "Rates vary significantly by surgeon, and initial BCS performed by high-volume surgeons was associated with a 33 percent lower risk for a reoperation."

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs